The Chinese healthcare market - the fastest growing in the world - benefits from the fact that the world's second largest economy is increasingly driven by (technological) innovation. The sector harbors great opportunities for investors, but there are also risks due to ESG issues - particularly on the G of governance - and tensions between China and the United States. Richard Carlyle, Equity Investment Director at Capital Group, points out the potential of the sector as well as the opportunities and risks.Investment Officer is an editorially independent media platform in the Benelux countries providing industry news and insights to investment professionals working for asset owners, asset managers and asset servicing companies. The Netherlands: http://www.investmentofficer.nlBelgium: http://www.investmentofficer.beLuxembourg: http://www.investmentofficer.lu